Constitutive expression of the steroid sulfatase gene supports the growth of MCF-7 human breast cancer cells in vitro and in vivo

Endocrinology

Volumn 142, Issue 4, 2001, Pages 1497-1505

  James, M R ^a   Skaar, T C ^a   Lee, R Y ^a   MacPherson, A ^a   Zwiebel, J A ^a   Ahluwalia, B S ^a   Ampy, F ^a   Clarke, R ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17BETA ESTRADIOL SULFATE; ANTIESTROGEN; ESTRADIOL; ESTRADIOL DERIVATIVE; ESTRONE; ESTRONE SULFATE; MESSENGER RNA; PROGESTERONE; STERYL SULFATASE; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENICITY; CELL CLONE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REACTION TIME; RETROVIRUS; SOUTHERN BLOTTING; TUMOR PROMOTION;

EID: 0035053009     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.4.8091     Document Type: Article

References (63)

1. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue
2. 3H-oestradiol by normal breast and breast tumor tissues in post-menopausal women
3. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients
4. Uptake and synthesis of steroid hormones by the breast
5. Mechanism for maintenance of high breast tumor estradiol concentrations in the absence of ovarian function: Role of very high affinity tissue uptake
6. Differential estrogen substrate specificities for transiently expressed human placental 17β-hydroxysteroid dehydrogenase and an endogenous enzyme expressed in cultured COS-m6 cells
7. Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines
8. Recent data on estrogen sulfatases and sulfotransferases activities in human breast cancer
9. A correlation between estrogen sulfotransferase levels and estrogen receptor status in human primary breast carcinoma
10. Control and expression of oestrone sulphatase activities in human breast cancer
11. In situ estrogen production via the estrone sulfate pathway in breast tumors: Relative importance versus the aromatase pathway
12. Future use of aromatase inhibitors in breast cancer
13. Significance of aromatase activity in human breast cancer
14. Estrone and estradiol content in human breast tumors: Relationship to estradiol receptors
15. Aromatase, 17β-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women
16. Estrogens, phytoestrogens and breast cancer
17. First generation aromatase inhibitors-aminoglutethimide and testololactone
18. Treatment of breast cancer with aromatase inhibitors - Current status and future prospects
19. Alterations in the production and clearance rate of estrone and estrone sulfate in breast cancer patients treated with aminoglutethimide
20. Postmenopausal estrogen biosynthesis and metabolism: Alterations caused by aromatase inhibitors used for the treatment of breast cancer
21. Prognostic significance of aromatase and estrone sulfatase enzymes in human breast cancer
22. Prognostic value of breast cancer aromatase
23. Intratumoral oestrone sulphatase activity as a prognostic marker in human breast carcinoma
24. Prolonged retention of estradiol by human breast cancer cells in tissue culture
25. Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells
26. The inter-relationships between ovarian-independent growth, antiestrogen resistance and invasiveness in the malignant progression of human breast cancer
27. Effect of estradiol on human breast cancer cells in culture
28. Improved retroviral vectors for gene transfer and expression
29. Safe and efficient ecotropic and amphotropic packaging lines for use in gene transfer experiments
30. The effects of a constitutive production of TGF-α on the growth of MCF-7 human breast cancer cells in vitro and in vivo
31. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production
32. Progression from hormone dependent to hormone independent growth in MCF-7 human breast cancer cells
33. Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells
34. MCF7/LCC9: An antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182, 780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen
35. 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal protein PO
36. Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectble DNA amplifications
37. The hydrolysis of estrone sulfate and dehydroepiandrostenedione sulfate by MCF-7 human breast cancer cells
38. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis
39. Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice
40. Serum steroid levels in intact and endocrine ablated BALB nude mice and their intact litter mates
41. Issues in experimental design and endpoint analysis in the study of experimental cytotoxic agents in vivo in breast cancer and other models
42. Human breast cancer cell line xenograffs as models of breast cancer: The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines
43. Cloning and expression of steroid sulfatase cDNA and the frequent occurrence of deletions in STS deficiency: Implications for X-Y interchange
44. Detection of breast cancer-associated estrone sulfatase in breast cancer biopsies and cell lines using polymerase chain reaction
45. Effect of the progestagen promegesterone (R-5020) on mRNA of the estrone sulfatase in the MCF-7 human mammary cancer cells
46. New assay for steroid sulfatase (EC 3.1,6.2) and its application for studies of human placental and skin sulfatase
47. Estrogen sulfates: Biological and ultrastructural responses and metabolism in MCF-7 human breast cancer cells
48. Estrone sulfate promotes human breast cancer cell replication and nuclear uptake of estradiol in MCF-7 cell cultures
49. Estrone sulfatase activity and effect of antiestrogens on transformation of estrone sulfate in hormone-dependent vs independent human breast cancer cell lines
50. Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells
51. The effect of combining aromatase inhibitors with antiestrogens on tumor growth in a nude mouse model for breast cancer
52. Estrone sulfate stimulates growth of nitrosomethylurea-induced breast carcinoma in vivo in the rat
53. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man
54. Acquired estrogen independence and antiestrogen resistance in breast cancer: Estrogen receptor-driven phenotypes?
55. Effect of nomegestrol acetate on estrone-sulfatase and 17β-hydroxysteroid dehydrogenase activities in breast cancer cells
56. Covalent binding of 17β-estradiol and retinoic acid to proteins in the human breast cancer cell line MCF-7
57. Steroid sequestration and tightly bound oestrogen-protein complexes in human breast tumors and a breast cancer cell line
58. Tamoxifen and 17β-estradiol reduce the membrane fluidity of human breast cancer cells
59. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium
60. Aromatase in the normal breast and breast cancer
61. Breast cancer and expression of aromatase in breast adipose tissue
62. Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate: A potential therapeutic agent in breast cancer